The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


Drug Intelligence & Clinical Pharmacy: Vol. 17, No. 2, pp. 110-120.
© 1983 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sorkin, E.
Right arrow Articles by Darvey, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sorkin, E.
Right arrow Articles by Darvey, D.


Research Articles

Review of cimetidine drug interactions

EM Sorkin and DL Darvey

The literature on cimetidine drug interactions has been thoroughly reviewed. Several different mechanisms have been proposed for cimetidine-related drug interactions. These mechanisms include: (1) impaired hepatic drug metabolism due to inhibition of hepatic microsomal enzymes, (2) reduced hepatic blood flow, resulting in decreased clearance of drugs that are highly extracted by the liver, (3) increased potential for myelosuppression when administered concurrently with other drugs capable of causing myelosuppression, and (4) altered bioavailability of acid-labile drugs. Cimetidine binds reversibly to the hepatic cytochrome P-450 and P-448 systems, resulting in decreased metabolism of drugs that undergo Phase I reactions (e.g., dealkylation and hydroxylation). In contrast, glucuronidation pathways are unaffected. The rapid onset and reversal of cimetidine's inhibition of hepatic metabolism indicates an effect on hepatic enzyme systems. Cimetidine also has been reported to decrease hepatic blood flow. Drugs that are highly extracted by the liver, such as propranolol, lidocaine, and morphine, may be postulated to have a decreased hepatic clearance. Cimetidine, through its effect on gastric pH, may increase the absorption of acid-labile drugs or may decrease the absorption of drugs. There have been reports of increased potential for myelosuppression when cimetidine is administered concurrently with drugs capable of causing bone marrow suppression. An understanding of the mechanisms involved in cimetidine drug interactions allows the clinician to prevent and predict these interactions.


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
R. Stadel, J. Yang, J. W. Nalwalk, J. G. Phillips, and L. B. Hough
High-Affinity Binding of [3H]Cimetidine to a Heme-Containing Protein in Rat Brain
Drug Metab. Dispos., March 1, 2008; 36(3): 614 - 621.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
E. R. Gonzalez
Pharmacological Approach to the Prevention and Treatment of Stress Ulcers
J Intensive Care Med, December 1, 1990; 5(1S): S10 - S16.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
L. A. Cannon, D. Heiselman, W. Gardner, and J. Jones
Prophylaxis of Upper Gastrointestinal Tract Bleeding in Mechanically Ventilated Patients: A Randomized Study Comparing the Efficacy of Sucralfate, Cimetidine, and Antacids
Arch Intern Med, December 1, 1987; 147(12): 2101 - 2106.
[Abstract] [PDF]


Home page
Arch NeurolHome page
B. A. Wroblewski and W. H. Garvin Jr
Once-Daily Administration of Phenobarbital in Adults: Clinical Efficacy and Benefit
Arch Neurol, July 1, 1985; 42(7): 699 - 700.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
D. JACK, R. N. SMITH, and P. J. WISE
Ranitidine and Cimetidine
Ann Intern Med, May 1, 1984; 100(5): 768 - 769.
[Abstract] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1983 by Harvey Whitney Books Company.